MLICM
KALA icon

Metropolitan Life Insurance Company (MetLife)’s KALA BIO KALA Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio KALA Stock Details KALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-4
Closed -$74.8K – 2594
2020
Q4 		$74.8K Sell
4
-1
-20% -$18.8K ﹤0.01% 2440
2020
Q3 		$96.8K Hold
5
– – ﹤0.01% 2236
2020
Q2 		$136K Buy
5
+2
+67% +$56.7K ﹤0.01% 2064
2020
Q1 		$75.9K Buy
+3
New +$47.9K ﹤0.01% 2210
2018
Q2 		– Sell
-2
Closed -$83.6K – 2477
2018
Q1 		$83.6K Buy
+2
New +$75.9K ﹤0.01% 2365
2017
Q4 		– Sell
-5
Closed -$258K – 2510
2017
Q3 		$258K Buy
+5
New +$274K ﹤0.01% 2128

Other funds holding KALA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s KALA Position: Q1 2021 in Review

Metropolitan Life Insurance Company (MetLife) sold out of KALA BIO (KALA) in Q1 2021, closing a stake of 4 shares — an estimated $74.8K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in KALA in Q3 2017 and held it in 6 quarters. The position peaked at $258K in Q3 2017. 106 funds tracked by Wall St. Rank hold KALA as of Q1 2021.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining KALA BIO position as of Q1 2021 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 4 KALA BIO shares in Q1 2021, an estimated $74.8K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in KALA BIO in Q3 2017 and held it in 6 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s KALA BIO position peaked at $258K in Q3 2017.
  • 106 funds tracked by Wall St. Rank held KALA BIO as of Q1 2021.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2021, filed 14 May 2021.